DCR-5 bone affecting ligand
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsAris N. Economides, Neil Stahl
Life of this patent
Estimating the term…
Abstract
DCR5, a protein related to DAN (Differential-screening-selected gene Aberrative in Neuroblastoma) and related nucleic acids are provided. Included are natural DCR5 homologs from several species and proteins comprising a DCR5 domain having specific activity, particularly the ability to antagonize a bone morphogenetic protein. The proteins may be produced recombinantly from transformed host cells with the subject nucleic acids. Also provided are isolated hybridization probes and primers capable of specifically hybridizing with the disclosed genes, specific binding agents and methods of making and using the subject compositions.
Claims13
Isolated human DCR5 protein.
A human DCR5 protein produced by the method of:
- a) constructing a vector comprising a nucleic acid molecule containing a nucleotide sequence encoding human DCR5 protein as set forth in SEQ ID NO:
- 12, wherein the nucleic acid molecule is operatively linked to an expression control sequence capable of directing its expression in a host cell;
- b) introducing the vector of (a) into a host cell;
- c) growing the host cell of (b) under conditions which permit the production of human DCR5 protein;
- and
- d) recovering the human DCR5 protein so produced.
Dependencies are inferred from the claim text.